Association of Longitudinal Risk Profile Trajectory Clusters with Adipose Tissue Depots Measured by Magnetic Resonance Imaging

Overview

Journal Sci Rep

Specialty Science

Date 2019 Nov 20

PMID 31740739

Citations 10

Authors

Susanne Rospleszcz

Roberto Lorbeer

Corinna Storz

Christopher L Schlett

Christa Meisinger

Barbara Thorand

Wolfgang Rathmann

Fabian Bamberg

Wolfgang Lieb

Annette Peters

Affiliations

Soon will be listed here.

Abstract

The objective of the study was to identify associations of longitudinal trajectories of traditional cardiometabolic risk factors with abdominal and ectopic adipose tissue depots measured by magnetic resonance imaging (MRI). We measured total abdominal, visceral, and subcutaneous adipose tissue in liter and intrahepatic, intrapancreatic and renal sinus fat as fat fractions by MRI in 325 individuals free of cardiovascular disease at Exam 3 of a population-based cohort. We related these MRI measurements at Exam 3 to longitudinal risk profile trajectory clusters, based on risk factor measurements from Exam 3, Exam 2 (seven years prior to MRI) and Exam 1 (14 years prior to MRI). Based on the levels and longitudinal trajectories of several risk factors (blood pressure, lipid profile, anthropometric measurements, HbA1c), we identified three different trajectory clusters. These clusters displayed a graded association with all adipose tissue traits after adjustment for potential confounders (e.g. visceral adipose tissue: β = 1.30 l, 95%-CI:[0.84 l;1.75 l], β = 3.32 l[2.74 l;3.90 l]; intrahepatic: Estimate = 1.54[1.27,1.86], Estimate = 2.48[1.93,3.16]. Associations remained statistically significant after additional adjustment for the risk factor levels at Exam 1 or Exam 3, respectively. Trajectory clusters provided additional information in explaining variation in the different fat compartments beyond risk factor profiles obtained at individual exams. In conclusion, sustained high risk factor levels and unfavorable trajectories are associated with high levels of adipose tissue; however, the association with cardiometabolic risk factors varies substantially between different ectopic adipose tissues. Trajectory clusters, covering longitudinal risk profiles, provide additional information beyond single-point risk profiles. This emphasizes the need to incorporate longitudinal information in cardiometabolic risk estimation.

Citing Articles

The moderating effect of cardiometabolic factors on the association between hepatic and intrapancreatic fat.

Skudder-Hill L, Sequeira-Bisson I, Ko J, Poppitt S, Petrov M Obesity (Silver Spring). 2024; 32(12):2310-2320.

PMID: 39523209 PMC: 11589540. DOI: 10.1002/oby.24154.

Clusters of longitudinal risk profile trajectories are associated with cardiometabolic diseases: Results from the population-based KORA cohort.

Niedermayer F, Schauberger G, Rathmann W, Klug S, Thorand B, Peters A PLoS One. 2024; 19(3):e0300966.

PMID: 38547172 PMC: 10977748. DOI: 10.1371/journal.pone.0300966.

Adipose tissue is associated with kidney function parameters.

Mueller-Peltzer K, von Kruchten R, Lorbeer R, Rospleszcz S, Schulz H, Peters A Sci Rep. 2023; 13(1):9151.

PMID: 37280396 PMC: 10244418. DOI: 10.1038/s41598-023-36390-z.

Parental obesity-induced changes in developmental programming.

Cechinel L, Batabyal R, Freishtat R, Zohn I Front Cell Dev Biol. 2022; 10:918080.

PMID: 36274855 PMC: 9585252. DOI: 10.3389/fcell.2022.918080.

Precision MRI phenotyping enables detection of small changes in body composition for longitudinal cohorts.

Whitcher B, Thanaj M, Cule M, Liu Y, Basty N, Sorokin E Sci Rep. 2022; 12(1):3748.

PMID: 35260612 PMC: 8904801. DOI: 10.1038/s41598-022-07556-y.

References

Will S, Martirosian P, Wurslin C, Schick F . Automated segmentation and volumetric analysis of renal cortex, medulla, and pelvis based on non-contrast-enhanced T1- and T2-weighted MR images. MAGMA. 2014; 27(5):445-54. DOI: 10.1007/s10334-014-0429-4. View

Booth A, Magnuson A, Foster M . Detrimental and protective fat: body fat distribution and its relation to metabolic disease. Horm Mol Biol Clin Investig. 2014; 17(1):13-27. DOI: 10.1515/hmbci-2014-0009. View

Buzzetti E, Pinzani M, Tsochatzis E . The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016; 65(8):1038-48. DOI: 10.1016/j.metabol.2015.12.012. View

Zelicha H, Schwarzfuchs D, Shelef I, Gepner Y, Tsaban G, Tene L . Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial. Clin Nutr. 2017; 37(4):1145-1153. DOI: 10.1016/j.clnu.2017.04.007. View

Frank A, de Souza Santos R, Palmer B, Clegg D . Determinants of body fat distribution in humans may provide insight about obesity-related health risks. J Lipid Res. 2018; 60(10):1710-1719. PMC: 6795075. DOI: 10.1194/jlr.R086975. View

Sinning C, Kieback A, Wild P, Schnabel R, Ojeda F, Appelbaum S . Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study. Clin Res Cardiol. 2014; 103(6):477-85. DOI: 10.1007/s00392-014-0674-6. View

Newton Jr R, Bouchard C, Bray G, Greenway F, Johnson W, Ravussin E . Abdominal adiposity depots are correlates of adverse cardiometabolic risk factors in Caucasian and African-American adults. Nutr Diabetes. 2012; 1:e2. PMC: 3302129. DOI: 10.1038/nutd.2010.2. View

Speliotes E, Massaro J, Hoffmann U, Vasan R, Meigs J, Sahani D . Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010; 51(6):1979-87. PMC: 3023160. DOI: 10.1002/hep.23593. View

VanWagner L, Khan S, Ning H, Siddique J, Lewis C, Carr J . Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study. Liver Int. 2017; 38(4):706-714. PMC: 5867197. DOI: 10.1111/liv.13603. View

10.

Abraham T, Pedley A, Massaro J, Hoffmann U, Fox C . Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015; 132(17):1639-47. PMC: 4779497. DOI: 10.1161/CIRCULATIONAHA.114.015000. View

11.

Polyzos S, Kountouras J, Mantzoros C . Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2018; 92:82-97. DOI: 10.1016/j.metabol.2018.11.014. View

12.

Neeland I, Turer A, Ayers C, Berry J, Rohatgi A, Das S . Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol. 2015; 65(19):2150-1. PMC: 4890465. DOI: 10.1016/j.jacc.2015.01.061. View

13.

Hu X, Li Y, Li L, Zheng Y, Lv J, Huang S . Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. BMJ Open. 2018; 8(4):e019974. PMC: 5892783. DOI: 10.1136/bmjopen-2017-019974. View

14.

Holle R, Happich M, Lowel H, Wichmann H . KORA--a research platform for population based health research. Gesundheitswesen. 2005; 67 Suppl 1:S19-25. DOI: 10.1055/s-2005-858235. View

15.

Nimptsch K, Konigorski S, Pischon T . Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism. 2018; 92:61-70. DOI: 10.1016/j.metabol.2018.12.006. View

16.

Chughtai H, Morgan T, Rocco M, Stacey B, Brinkley T, Ding J . Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension. 2010; 56(5):901-6. PMC: 3634339. DOI: 10.1161/HYPERTENSIONAHA.110.157370. View

17.

Dale C, Fatemifar G, Palmer T, White J, Prieto-Merino D, Zabaneh D . Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis. Circulation. 2017; 135(24):2373-2388. PMC: 5515354. DOI: 10.1161/CIRCULATIONAHA.116.026560. View

18.

Idilman I, Tuzun A, Savas B, Elhan A, Celik A, Idilman R . Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging. 2015; 40(6):1512-9. DOI: 10.1007/s00261-015-0385-0. View

19.

Hagg S, Fall T, Ploner A, Magi R, Fischer K, Draisma H . Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. Int J Epidemiol. 2015; 44(2):578-86. PMC: 4553708. DOI: 10.1093/ije/dyv094. View

20.

Lee J, Pedley A, Hoffmann U, Massaro J, Levy D, Long M . Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study. Am J Med. 2018; 131(6):684-692.e12. PMC: 5964004. DOI: 10.1016/j.amjmed.2018.02.002. View